NASDAQ:GRFS

Grifols Stock Predictions

NASDAQ Stock Exchange > Healthcare > Drug Manufacturers—General

Open Broker Account

$6.84

+0.0400 (+0.588%)

At Close: May 08, 2024

Currently predicting for Thu, 9 May 2024

Trading levels for GRFS

Fibonacci Support & Resistance Levels

		Level	Price
	Resistance	R3	7.00	2.39 %
		R2	6.96	1.69 %
		R1	6.93	1.26 %
Current price:			6.84
	Support	S1	6.83	-0.138 %
		S2	6.80	-0.569 %
		S3	6.75	-1.27 %

Accumulated Volume Support & Resistance Levels

		Level	Price
	Resistance	R3	7.51	9.80 %
		R2	7.06	3.22 %
		R1	7.00	2.34 %
Current price			6.84
	Support	S1	6.78	-0.88%
		S2	6.29	-8.04%
		S3	5.47	-20.03%

GRFS Predictions History

8 years ago
JS predicted that GRFS for 2016-04-27 is going $15.78 (-1.68%)

About Grifols

Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solutions to treat patients with chronic, rare, prevalent, and life-threatening diseases. It offers immunogl... GRFS Profile

Golden Star

Ticker	Date	Change	Price
VCSH	May 03	0.0130%	$76.93
BNDX	May 03	0.349%	$48.68
BBCA	May 03	1.26%	$65.44
ISTB	May 03	0.0425%	$47.11
ADTH	May 03	5.56%	$3.24
WMT	May 03	1.34%	$59.82
UNP	May 03	0.84%	$240.36
INGR	May 03	1.75%	$114.56
ASH	May 03	2.26%	$95.85
WU	May 03	0.449%	$13.37

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In